Opti Capital Management, LP - Q4 2021 holdings

$1.32 Billion is the total value of Opti Capital Management, LP's 37 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .

 Value Shares↓ Weighting
 DICKS SPORTING GOODS INCnote 3.250% 4/1$105,026,000
-3.5%
29,655,0000.0%7.97%
-22.0%
 SUPERNUS PHARMACEUTICALSnote 0.625% 4/0$45,147,000
+0.7%
45,402,0000.0%3.42%
-18.6%
 VEECO INSTRS INC DELnote 3.750% 6/0$40,515,000
+23.0%
18,500,0000.0%3.07%
-0.6%
 MANDIANT INCnote 1.625% 6/0$31,387,0000.0%31,309,0000.0%2.38%
-19.2%
 KBR INCnote 2.500%11/0$30,570,000
+18.7%
16,000,0000.0%2.32%
-4.0%
 REPLIGEN CORPnote 0.375% 7/1$24,755,000
-7.2%
10,534,0000.0%1.88%
-25.0%
 MODEL N INCnote 2.625% 6/0$14,057,000
-7.5%
12,000,0000.0%1.07%
-25.2%
 KARYOPHARM THERAPEUTICS INCnote 3.000%10/1$12,230,000
+6.9%
14,960,0000.0%0.93%
-13.5%
 PTC THERAPEUTICS INCnote 3.000% 8/1$8,505,000
+1.5%
8,000,0000.0%0.64%
-18.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SUPERNUS PHARMACEUTICALS INC14Q1 20236.9%
NEW RELIC INC14Q1 20237.6%
8X8 INC NEW13Q3 20237.4%
MANDIANT INC12Q1 20229.9%
NUTANIX INC12Q4 20227.3%
OPKO HEALTH INC12Q3 20232.1%
INSIGHT ENTERPRISES INC10Q3 20235.6%
ALTERYX INC10Q3 20234.6%
IONIS PHARMACEUTICALS INC10Q1 20233.6%
MODEL N INC10Q3 20231.7%

View Opti Capital Management, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Opti Capital Management, LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1318507000.0 != 1318505000.0)

Export Opti Capital Management, LP's holdings